Skip to content

Comparative fat absorption in healthy termed infants consuming infant formulae with different fat blends.

Comparative fat absorption in healthy termed infants consuming infant formulae with different fat blends.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23088
Enrollment
44
Registered
2017-12-01
Start date
2017-12-05
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Absorption of fat and calcium, gut comfort, stool consistency.

Interventions

Following recruitment and before treatment allocation all infants will be fed with a standard formula and this will be considered as a wash-out period. After the washout period, at week 0, half of the

Sponsors

FrieslandCampina N.V.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Full-term, healthy infants (born at gestational age ≥37 weeks). - "Appropriate for gestational age" birthweight (i.e. 10th centile ≤ Birth weight ≤ 90th centile). - Age at enrolment: between 9th-14th week - Exclusively formula fed infants before and during the entire intervention period. - Parents willing and agreeing to initiate complementary feeding after the end of endpoint measurements, i.e. after the completion of the 5th month of age - Parents willing to collect stools and fill in all study questionnaires and diaries during the entire intervention period - Written informed consent

Exclusion criteria

Exclusion criteria: - Severe acquired or congenital diseases, mental or physical disorders, any symptoms of allergy (including cow¡¯s milk allergy). - No parents or siblings with documented CMA allergy, diagnosed by a doctor. - Use of probiotics, antibiotics or other medication that treats or causes GI symptoms and/or affect appetite at the time of screening or at any time throughout the study period (these infants will be considered as drop-outs). - Use of medication(s) known or suspected to affect fat digestion, absorption and/or metabolism; nutritional supplements; suppositories; medication that may suppress or neutralize gastric acid secretion and gut mobility at the time of screening or at any time throughout the study period (these infants will be considered as drop-outs). - Participation in another clinical trial. - Any type of mixed feeding (i.e. combination of formula with breastfeeding in any proportion) and/or complementary feeding during the intervention.

Design outcomes

Primary

MeasureTime frame
Fatty acids absorption

Secondary

MeasureTime frame
Calcium absorption and gut comfort.

Contacts

Public ContactFrieslandCampina Innovation Centre
inge.thijs-verhoeven@frieslandcampina.com0031 6 13248135

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)